Start here · since 1996

Psychedelics Guide

More than 500 articles organized by substance and topic: psilocybin, LSD, ayahuasca, DMT, MDMA, mescaline and harm reduction. Rigorous information, without fear and without propaganda.

Featured articles

Explore the largest archive on psychoactive substances, published since 1996

US Psychedelic Helpline: Insights from 25,419 Interactions

A Science Advances paper details 25,419 contacts with the Fireside Project (2021-2026), primarily regarding psilocybin and trip support. Among interactions with recorded history, 2.4% mentioned schizophrenia. The data reflects only those who reached out.

Persistent difficulties after psychedelics or meditation: Emory publishes a protocol for a 1,600-person study

A team led by Emory University has posted on medRxiv the protocol for an observational study that will follow, for one year, people who attribute persistent difficulties to psychedelics or meditation. It is a research plan with no data. The sample is deliberately recruited among affected people, so it is not designed to estimate how often these problems occur.

Mind & Spirit

Inspiring reads for open minds

From our readers

Articles chosen by our community of readers

Send us your story and get featured on our homepage

Imagination and Cannabis: What Really Changes?

Cannabis doesn't invent foreign images; it modulates an existing faculty. We review what imagination is and how it is altered, with a critical eye.

Piracetam: The Origin of Smart Drugs

Piracetam is the standard nootropic, the one we might consider the father of smart drugs. It was first synthesized in 1964 by the team led by Corneliu Giurgea at the Belgian pharmaceutical company UCB (Union Chimique Belge), which was founded in 1928 and specialized in, among other things, medications for the nervous system.

Cannabis, Anxiety, and Self-Regulation: Mental Space or Escapism?

Self-control versus hyperarousal and distress: what role is attributed to cannabis, and why should we approach these claims with a critical eye?

Recreational vs. Clinical Ketamine: Uses and Harm Reduction

What separates supervised clinical ketamine from recreational use: mechanisms, EMA and FDA-approved indications, bladder and kidney risks, and harm reduction.

MDMA, Fear, and Empathy: What Affective Neuroscience Reveals

Affective neuroscience shows that MDMA reduces fear recognition while enhancing positive emotions. We review key studies and their limitations.

News

The latest from the psychedelic world

Latest articles

Browse our most recent articles